Legal & General · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
Legal & General Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 2.4M | $1.0B | — |
| 2024Q2 | 4.9M | $2.1B | +113.6% |
| 2024Q3 | 4.7M | $2.1B | +0.4% |
| 2024Q4 | 3.9M | $1.7B | -23.1% |
| 2025Q1 | 8.2M | $3.5B | +114.2% |
| 2025Q2 | 2.0M | $844M | -76.1% |
| 2025Q3 | 2.0M | $767M | -9.2% |
| 2025Q4 | 2.0M | $895M | +16.7% |
| 2026Q1 | 2.0M | $874M | -2.3% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F